Teresa Wu graduated from University College London and studied MSc in Clinical Neurosciences at Institute of Neurology, UCL. She joined a research group at Imperial College London to study oligodendrocyte myelination with reference to multiple sclerosis, before starting a placement at Guy’s and St Thomas’ Hospitals as a Trainee Clinical Biochemist. Teresa moved to Great Ormond Street Hospital to specialise in Paediatric Biochemistry and Inborn Errors of Metabolism.
In 2008 she moved to Manchester as Principal Clinical Scientist in the Newborn Screening & Metabolites Section at the Willink Metabolic Unit, and then appointed Deputy Director of Willink Biochemical Genetics Laboratory and Head of Screening & Metabolites Section in 2012. Teresa specialises in the application of tandem mass spectrometry in the screening, diagnosis and monitoring of inborn errors of metabolism, and has recently developed an interest in biochemical diagnosis of Niemann Pick disease type C.
Teresa is Secretary of the UK Newborn Screening Laboratory Network since 2015. She lectures for the Paediatric Biochemistry module on the MSc Clinical Biochemistry at University of Manchester and is the Training Officer of the Willink Biochemical Genetics Laboratory.